Healthcare and Life Sciences

Contact Us

Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.

Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.

/industries/healthcare-and-life-sciences /-/media/feature/industries/desktop/health-life-sciences.jpg industry {13E28841-C245-441D-8C3B-49E72DA5381C} {BAF3E1CE-54B1-4448-B2FD-00B1585CD18A} {9B44E83A-E993-4902-AAE0-82849CEAD728} {E010DCD9-B7BA-4B98-9F3C-A51506B5C1D8} {4DACD310-421A-42AC-BEF4-8AA7E70484CD}

Other Areas We Can Help

Financial Sponsor Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsor Group

Valuation Services

Valuation and asset appraisal for financial reporting, income tax, investment and risk management purposes.

Valuation Services

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior execution.

M&A Advisory

Case Studies

Insights

M&A Advisory

Healthcare Services Sector Update – December 2020

M&A Advisory
Valuation

Transaction Trail Annual Report 2020

Valuation
M&A Advisory

Global Telco Infrastructure Update – Q4 2020

M&A Advisory
Cost of Capital

Duff & Phelps Recommended U.S. Equity Risk Premium Decreased from 6.0% to 5.5%, Effective December 9, 2020

Cost of Capital

News

Featured Events